Publications by authors named "Pier F Bassi"

Claim this Profile
T
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer.
Valeria Pecci, Fabiola Troisi, Aurora Aiello, Sara De Martino, Angela Carlino, Pier Francesco Bassi

Cancer Cell Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group.
Francesco Pierconti, Esther Diana Rossi, Tonia Cenci, Angela Carlino, Vincenzo Fiorentino, Pier Francesco Bassi

Cancer Cytopathol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives.
Roberto Iacovelli, Carlo Maria Cicala, Chiara Ciccarese, Emilio Sacco, Marco Racioppi, Pier Francesco Bassi

Urologia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma.
Francesco Pierconti, Maurizio Martini, Tonia Cenci, Vincenzo Fiorentino, Luca Di Gianfrancesco, Pier Francesco Bassi

Urol Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.
Francesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, Tonia Cenci, Marco Racioppi, Pier Francesco Bassi

Hum Pathol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation study of the Paris system for reporting urinary (TPS) categories.
Francesco Pierconti, Maurizio Martini, Tonia Cenci, Vincenzo Fiorentino, Emilio Sacco, Pier Francesco Bassi

J Clin Pathol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
Francesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, Tonia Cenci, Sara Capodimonti, Pier Francesco Bassi

Urol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy.
Vincenzo Fiorentino, Maurizio Martini, Marco Dell'Aquila, Teresa Musarra, Ersilia Orticelli, Pier Francesco Bassi

Diagnostics (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders.
Francesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, Luigi Maria Larocca, Pier Francesco Bassi

Virchows Arch· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders.
Francesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, Luigi Maria Larocca, Pier Francesco Bassi

Virchows Arch· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma.
Patrizia Straccia, Maurizio Martini, Emilio Sacco, Pier F Bassi, Francesco Pierconti

Diagn Cytopathol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diuresis renography in equivocal urinary tract obstruction. A historical perspective.
Girolamo Tartaglione, Danyelle M Townsend, Pier Francesco Bassi, Roberto C Delgado Bolton, Francesco Giammarile

Biomed Pharmacother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stone composition and vascular calcifications in patients with nephrolithiasis.
Pietro Manuel Ferraro, Riccardo Marano, Aniello Primiano, Jacopo Gervasoni, Matteo Bargagli, Pier Francesco Bassi

J Nephrol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer.
Lorenza Bacci, Aurora Aiello, Cristian Ripoli, Rossella Loria, Dario Pugliese, Pier Francesco Bassi

Int J Mol Sci· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ Cell Neoplasia (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs).
Francesco Pierconti, Maurizio Martini, Giuseppe Grande, Luigi M Larocca, Emilio Sacco, Pier F Bassi

Front Endocrinol (Lausanne)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, Giuseppe Palermo, Emilio Sacco, Pier Francesco Bassi

Int Braz J Urol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions.
Roberto Iacovelli, Chiara Ciccarese, Giovanni Schinzari, Brigida Anna Maiorano, Ernesto Rossi, Pier Francesco Bassi

Crit Rev Oncol Hematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts.
Francesco Pierconti, Esther D Rossi, Maurizio Martini, Emilio Sacco, Pier F Bassi

Appl Immunohistochem Mol Morphol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes.
Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, Giuseppe Palermo, Emilio Sacco, Pier Francesco Bassi

BMC Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in renal papillary density after hydration therapy in calcium stone formers.
Pietro Manuel Ferraro, Matteo Vittori, Giuseppe Macis, Alessandro D'Addessi, Gianmarco Lombardi, Pier Francesco Bassi

BMC Urol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study.
Angelo Porreca, Marianna Noale, Walter Artibani, Pier Francesco Bassi, Filippo Bertoni

Health Qual Life Outcomes· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy)" [Pathol. Res. Pract. 213 (2017) 1078-1081].
Francesco Pierconti, Patrizia Straccia, Sacco Emilio, Pier Francesco Bassi, Ivana De Pascalis

Pathol Res Pract· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration.
Francesco Pierconti, Esther Diana Rossi, Patrizia Straccia, Guido Fadda, Luigi Maria Larocca, Pier Francesco Bassi

Cancer Cytopathol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life After Prostate Cancer Diagnosis: Data from the Pros-IT CNR.
Mauro Gacci, Marianna Noale, Walter Artibani, Pier Francesco Bassi, Filippo Bertoni

Eur Urol Focus· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy).
Francesco Pierconti, Patrizia Straccia, Sacco Emilio, Pier Francesco Bassi, Ivana De Pascalis

Pathol Res Pract· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis